Other specified and unspecified depressive disorders are diagnostic categories included in the DSM-5 for clinical conditions in which significant depressive symptoms are present but do not fully meet the criteria for one of the coded depressive syndromes (such as Major depressive disorder, dysthymia or premenstrual dysphoric disorder). In the DSM-IV-TR, this category replaced the definition of depressive disorder not otherwise specified (NOS), a label still widely used in everyday clinical practice.
The DSM-5 distinguishes two subcategories within this general definition:
Other specified depressive disorder: used when the clinician chooses to state the reason why full criteria are not met, such as insufficient duration or an insufficient number of symptoms.
Unspecified depressive disorder: used when the clinician does not wish or is unable to specify why full diagnostic criteria are not met, or when sufficient information is unavailable, such as in emergency settings.
Both labels are appropriate only when the clinical presentation is clearly depressive and causes significant impairment in the person's overall functioning.
Etiology
The etiology of atypical depressive disorders mirrors that of major, fully structured forms and can be attributed to interaction among multiple factors:
Genetic factors, with a more or less marked familial predisposition.
Neurochemical abnormalities, particularly involving serotonergic, noradrenergic and dopaminergic systems.
Dysfunction of the hypothalamic-pituitary-adrenal (HPA) axis, with abnormalities of cortisol and stress regulation.
Neuroendocrine imbalances, as in hypothyroidism or gonadal dysfunction.
Psychological and traumatic factors, especially during childhood and adolescence.
Pathogenesis and pathophysiology
Atypical or subsyndromal depressive forms are thought to arise from milder but chronic and pervasive abnormalities in neurobiological pathways involved in mood regulation. The principal abnormalities include:
Dysregulation of the limbic system and medial prefrontal cortex.
Reduced activity of mesolimbic dopaminergic circuits involved in motivation and reward.
Altered autonomic responses to environmental stimuli, including sleep-wake rhythms, appetite and emotional reactivity.
Clinically, these abnormalities result in unstable emotional functioning that is vulnerable to stress and prone to even minor mood fluctuations, which may nevertheless significantly interfere with quality of life.
I will now proceed with Block 2, which will include risk factors, clinical manifestations and diagnostic criteria.
Risk factors
Other specified and unspecified depressive disorders share many of the risk factors known for more fully structured mood disorders, despite the absence of complete syndromal presentations. The principal factors include:
Family history of mood disorders, particularly depressive or bipolar disorders.
Stressful events Recent or chronic stressful events, such as bereavement, separation, illness or relational trauma.
Psychiatric comorbidities, such as anxiety disorders, personality disorders—especially borderline personality disorder—or eating disorders.
Insecure attachment styles and difficulties with emotion regulation.
Certain chronic medical conditions, such as cancer, endocrine disorders or neurological diseases.
Clinical manifestations
Subsyndromal depressive forms are extremely heterogeneous. Symptoms resemble those of a major depressive episode but are attenuated or meet only incomplete criteria. Patients may report:
Persistent or fluctuating depressed mood
Easy fatigability and reduced energy
Loss of interest or pleasure in usual activities
Sleep or appetite disturbances
Low self-esteem, indecisiveness, feelings of emptiness or worthlessness
In some forms, such as premenstrual dysphoria or recurrent brief depression, symptoms may follow specific temporal patterns. Anxiety, irritability or affective lability may sometimes predominate over depressed mood itself.
Diagnosis and diagnostic criteria
The DSM-5 provides for the use of the designation “other specified depressive disorder” when the clinician wishes to communicate precisely why criteria for major depressive disorder, dysthymia or another disorder are not met. Examples of clinical presentations include:
Recurrent brief depression: episodes of depressed mood lasting 2 to 13 days and occurring at least once a month for 12 consecutive months.
Minor depression: depressive episodes lasting more than 2 weeks but with fewer than 5 symptoms, and therefore not meeting criteria for a major depressive episode.
Attenuated premenstrual dysphoric disorder: dysphoric symptoms during the luteal phase of the menstrual cycle, but with incomplete criteria compared with the full disorder.
Postpsychotic depression in schizophrenia: a depressive episode occurring after remission of a psychotic phase without meeting all criteria for major depressive disorder.
When the clinical form is not to be, or cannot be, specified, the category “unspecified depressive disorder” is used, typically in psychiatric emergency settings, incomplete assessments, complex cross-cultural contexts or atypical presentations.
Treatment, prognosis and complications
Treatment of other specified and unspecified depressive disorders is based on an individualized approach that considers severity, chronicity, functional impact and comorbidities. In the absence of specific guidelines, the principles applied to major depressive episodes are used with appropriate adaptations:
Psychological therapy: often the first recommended approach, especially in mild or subthreshold forms. The most effective techniques include cognitive behavioral therapy, interpersonal therapy and mindfulness-based therapy.
Pharmacological treatment: may be indicated when functional impact is high, significant anxiety comorbidity is present or psychotherapy alone has failed. Drugs of choice include SSRIs, SNRIs or atypical antidepressants such as bupropion. A mood stabilizer may also be useful in cyclical forms.
Psychoeducation: essential for early symptom recognition, relapse management and treatment adherence.
Complementary strategies: regular physical exercise, sleep hygiene and family support have demonstrated efficacy in improving clinical outcomes.
The prognosis is generally favorable in transient and context-related forms, but may be complicated by:
chronicity over time, such as progression to dysthymia or chronic major depressive disorder
frequent recurrence of episodes, particularly in recurrent brief depression
comorbidity with personality disorders, anxiety disorders or substance misuse
An important consideration is that these disorders may represent prodromal or attenuated forms of major affective disorders, particularly bipolar disorder, especially type II. Monitoring clinical evolution over time is therefore crucial.
The principal complications of other specified and unspecified depressive disorders include:
Progression to major depressive forms, especially when symptoms are persistent and underestimated
Impaired social, academic and occupational functioning, even in the absence of full criteria for a major episode
Increased suicide risk, especially in individuals with attenuated chronic depression and feelings of emptiness and hopelessness
Comorbidity with anxiety, somatic symptom or personality disorders, which may complicate classification and treatment response
References
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). American Psychiatric Publishing. Vol. 5, 2013.
American Psychiatric Association. DSM-IV-TR: Diagnostic and Statistical Manual of Mental Disorders, Text Revision. American Psychiatric Publishing. Vol. 4, 2000.
First MB et al. Structured Clinical Interview for DSM-5 Disorders (SCID-5). American Psychiatric Association Publishing. 2015.
Zimmerman M et al. Why some depressive disorders are not diagnosed in psychiatric practice. Comprehensive Psychiatry. Vol. 47, No. 5, 2006, pp. 324–328.
Angst J et al. The Hypomania Checklist (HCL-32): a tool for detecting bipolar II disorder. Journal of Affective Disorders. Vol. 88, No. 2, 2005, pp. 217–233.
Pini S et al. Depression in the medically ill: diagnosis, biology and treatment. CNS Drugs. Vol. 19, No. 7, 2005, pp. 537–555.
Fava GA et al. Subthreshold mood disorders: a clinical and therapeutic challenge. Psychotherapy and Psychosomatics. Vol. 73, No. 5, 2004, pp. 257–267.
Benazzi F. Minor depressive disorder and subthreshold depression: review of the literature. Acta Psychiatrica Scandinavica. Vol. 106, No. 6, 2002, pp. 402–408.
Rucci P et al. Subthreshold psychiatric disorders in the community: prevalence and impact on the use of health services. Social Psychiatry and Psychiatric Epidemiology. Vol. 38, No. 11, 2003, pp. 597–603.
Kessler RC et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. Vol. 289, No. 23, 2003, pp. 3095–3105.
